Literature DB >> 8376616

Predictors of valproate response in bipolar rapid cycling.

J R Calabrese1, M J Woyshville, S E Kimmel, D J Rapport.   

Abstract

Multiple regression/discriminant analyses were separately conducted to generate predictors of acute and prophylactic antimanic and depressive outcome in 101 valproate-treated bipolar rapid cyclers. Predictors of good antimanic response included decreasing or stable episode frequencies and nonpsychotic mania. Predictors of good antidepressant response included nonpsychotic mania worsening over the years of the illness and absence of borderline personality disorder comorbidity. This report confirms prior findings that indicate that valproate possesses marked acute and prophylactic antimanic and antimixed effects with only poor to moderate antidepressant properties.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376616

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  12 in total

1.  Gender Differences in Clinical Characteristics and Comorbidities in Bipolar Disorder: a Study from South India.

Authors:  Manjunadh Pillai; Ravindra Neelakanthappa Munoli; Samir Kumar Praharaj; Shripathy M Bhat
Journal:  Psychiatr Q       Date:  2020-09-05

Review 2.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 3.  A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures.

Authors:  R M Post; S R Weiss
Journal:  Mol Neurobiol       Date:  1996-08       Impact factor: 5.590

Review 4.  Current concepts in rapid cycling bipolar disorder.

Authors:  M D Shelton; J R Calabrese
Journal:  Curr Psychiatry Rep       Date:  2000-08       Impact factor: 5.285

5.  The social, psychopathological and consumer context of rate of symptom improvement in acute mania.

Authors:  Jim van Os; Inge van Rossum; Maarten Boomsma; Eduard Vieta; Iris Goetz; Catherine Reed; Josep Maria Haro
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-06-27       Impact factor: 4.328

6.  Anticonvulsant Use in the Treatment of Bipolar Disorder: A Primer for Primary Care Physicians.

Authors:  Raphael J. Leo; Rajesh Narendran
Journal:  Prim Care Companion J Clin Psychiatry       Date:  1999-06

7.  Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder.

Authors:  Arun Ravindran; Peter Silverstone; Denis Lacroix; Erno van Schaick; An Vermeulen; Jennifer Alexander
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.

Authors:  David E Kemp; Keming Gao; Stephen J Ganocy; Omar Elhaj; Sarah R Bilali; Carla Conroy; Robert L Findling; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2008-12-30       Impact factor: 4.384

9.  Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.

Authors:  Konstantinos N Fountoulakis; Eduard Vieta; Melina Siamouli; Marc Valenti; Stamatia Magiria; Timucin Oral; David Fresno; Panteleimon Giannakopoulos; George S Kaprinis
Journal:  Ann Gen Psychiatry       Date:  2007-10-09       Impact factor: 3.455

10.  Personality pathology predicts outcomes in a treatment-seeking sample with bipolar I disorder.

Authors:  Susan J Wenze; Brandon A Gaudiano; Lauren M Weinstock; Ivan W Miller
Journal:  Depress Res Treat       Date:  2014-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.